1. Home
  2. CVLT vs FOLD Comparison

CVLT vs FOLD Comparison

Compare CVLT & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commvault Systems Inc.

CVLT

Commvault Systems Inc.

HOLD

Current Price

$87.27

Market Cap

5.5B

Sector

Technology

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.30

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVLT
FOLD
Founded
1996
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.4B
IPO Year
2006
2007

Fundamental Metrics

Financial Performance
Metric
CVLT
FOLD
Price
$87.27
$14.30
Analyst Decision
Buy
Buy
Analyst Count
14
10
Target Price
$147.86
$26.11
AVG Volume (30 Days)
1.3M
8.1M
Earning Date
01-27-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.92
N/A
Revenue
$1,147,037,000.00
$598,704,000.00
Revenue This Year
$20.53
$21.49
Revenue Next Year
$11.58
$18.46
P/E Ratio
$44.82
N/A
Revenue Growth
21.52
21.28
52 Week Low
$79.51
$5.51
52 Week High
$200.69
$14.38

Technical Indicators

Market Signals
Indicator
CVLT
FOLD
Relative Strength Index (RSI) 31.98 78.81
Support Level $79.51 $14.30
Resistance Level $88.36 $14.31
Average True Range (ATR) 5.28 0.03
MACD -1.80 -0.12
Stochastic Oscillator 15.76 35.00

Price Performance

Historical Comparison
CVLT
FOLD

About CVLT Commvault Systems Inc.

CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Cleanroom Recovery, HyperScale X, Air Gap Protect, Compliance, Cloud Rewind, and Clumio Backtrack. The company operates in the United States and exports to many other countries.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: